lisofylline has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Abdelzaher, LA; Ali, M; Bakr, MH; Desai, AA; Mali, V; Radwan, E; Sayed, SA | 1 |
| Gu, J; Mison, A; Nadler, JL; Pei, H; Thimmalapura, PR | 1 |
| Berry, GJ; Bursten, S; Hasegawa, N; Nakayama, M; Oka, Y; Raffin, TA; Rice, G | 1 |
| Hasegawa, N; Murphy, GA; Nakayama, M; Oka, Y; Raffin, TA; Sussman, HH | 1 |
| Bright, JJ; Sriram, S | 1 |
1 review(s) available for lisofylline and Disease Models, Animal
| Article | Year |
|---|---|
Immunotherapy of inflammatory demyelinating diseases of the central nervous system.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-Positive T-Lymphocytes; Cerebrospinal Fluid; Chlamydia Infections; Chlamydophila pneumoniae; Cytokines; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Glatiramer Acetate; Humans; Immunotherapy; Inflammation; Interleukin-12; Mice; Multiple Sclerosis; Pentoxifylline; Peptides; Protein Kinase Inhibitors; Protein Kinases; Signal Transduction; Transforming Growth Factor beta | 2001 |
5 other study(ies) available for lisofylline and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Body Weight; Disease Models, Animal; Heart; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Myocardium; Obesity; Pentoxifylline; Signal Transduction; Up-Regulation | 2021 |
Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome.
Topics: Angioplasty, Balloon; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 12-Lipoxygenase; Blood Glucose; Body Weight; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Disease Models, Animal; Ectodysplasins; Female; Gene Expression; Inflammation; Insulin; Ki-67 Antigen; Lipids; Membrane Proteins; Metabolic Syndrome; Pentoxifylline; Phosphorylation; Rats; Rats, Zucker; STAT4 Transcription Factor; Tumor Necrosis Factors; Tunica Intima | 2006 |
The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs.
Topics: Adjuvants, Immunologic; Animals; Disease Models, Animal; Female; Hemodynamics; Lung; Male; Pentoxifylline; Phosphatidic Acids; Pseudomonas Infections; Respiratory Distress Syndrome; Shock, Septic; Swine; Swine, Miniature; Time Factors | 1997 |
Selective downregulation of neutrophils by a phosphatidic acid generation inhibitor in a porcine sepsis model.
Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Cell Adhesion; Disease Models, Animal; Fluid Therapy; Luminescent Measurements; Neutrophils; Pentoxifylline; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Swine; Swine, Miniature; Tetradecanoylphorbol Acetate; Time Factors | 1999 |